Environmental modulation of atherosclerosis end points in familial hypercholesterolemia

被引:22
作者
Hegele, RA [1 ]
机构
[1] Univ Western Ontario, John P Robarts Res Inst, Blackburn Cardiovasc Genet Lab, London, ON N6A 5K8, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/S1567-5688(01)00013-7
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
In familial hypercholesterolemia (FH), early coronary heart disease (CHD) is a complex trait that results from a large monogenic component of susceptibility due to elevated LDL cholesterol. This was demonstrated by observation of the high risk of early CHD in FH subjects compared with the general population. However, not all subjects with a LDLR gene mutation suffer with early CHD. Furthermore, studies in extended multigenerational families showed that even for this strong monogenic effect the environment could substantially modulate the age at death from CHD. Anecdotal examples of apparent modulation of atherosclerosis severity by lifestyle changes were also seen in other monogenic metabolic problems, such as hepatic lipase deficiency and Dunnigan-type familial partial lipodystrophy. Thus, even within apparently clear-cut rare monogenic metabolic diseases, such as FH, among carriers there can be a variability in the expression of important quantitative end points, such as early CHID. In some cases, the environment, including lifestyle factors, appears to play a key role in modulating the disease severity. This complexity could have implications for diagnosis and treatment. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:5 / 7
页数:3
相关论文
共 11 条
[1]   Nuclear lamin A/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy [J].
Cao, H ;
Hegele, RA .
HUMAN MOLECULAR GENETICS, 2000, 9 (01) :109-112
[2]   A multilocus genotyping assay for cardiovascular disease [J].
Cheng, S ;
Pallaud, C ;
Grow, MA ;
Scharf, SJ ;
Erlich, HA ;
Klitz, W ;
Pullinger, CR ;
Malloy, MJ ;
Kane, JP ;
Siest, G ;
Visvikis, S .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 1998, 36 (08) :561-566
[3]   The hepatic nuclear factor-1α G319S variant is associated with early-onset type 2 diabetes in Canadian Oji-Cree [J].
Hegele, RA ;
Cao, HI ;
Harris, SB ;
Hanley, AJG ;
Zinman, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (03) :1077-1082
[4]   INTERACTION BETWEEN VARIANT APOLIPOPROTEIN-C-II AND POLIPOPROTEIN-E THAT AFFECTS PLASMA-LIPOPROTEIN CONCENTRATIONS [J].
HEGELE, RA ;
BRECKENRIDGE, WC ;
COX, DW ;
MAGUIRE, GF ;
LITTLE, JA ;
CONNELLY, PW .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (05) :1303-1309
[5]   CLINICAL-APPLICATION OF DEOXYRIBONUCLEIC-ACID MARKERS IN A UTAH FAMILY WITH HYPERCHOLESTEROLEMIA [J].
HEGELE, RA ;
EMI, M ;
WU, LL ;
HOPKINS, PN ;
WILLIAMS, RR ;
LALOUEL, JM .
AMERICAN JOURNAL OF CARDIOLOGY, 1989, 63 (01) :109-112
[6]   RETRACTED: Candidate genes, small effects, and the prediction of atherosclerosis (Retracted article. See vol. 49, pg. 241, 2012) [J].
Hegele, RA .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1997, 34 (04) :343-367
[7]   APOLIPOPROTEIN-A-I Q[-2]X CAUSING ISOLATED APOLIPOPROTEIN-A-I DEFICIENCY IN A FAMILY WITH ANALPHALIPOPROTEINEMIA [J].
NG, DS ;
LEITER, LA ;
VEZINA, C ;
CONNELLY, PW ;
HEGELE, RA .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (01) :223-229
[8]   Phenotypic variation in heterozygous familial hypercholesterolemia - A comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada [J].
Pimstone, SN ;
Sun, XM ;
du Souich, C ;
Frohlich, JJ ;
Hayden, MR ;
Soutar, AK .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (02) :309-315
[9]  
*US DHHS, 1990, US DHHS PUBL
[10]   EVIDENCE THAT MEN WITH FAMILIAL HYPERCHOLESTEROLEMIA CAN AVOID EARLY CORONARY DEATH - AN ANALYSIS OF 77 GENE CARRIERS IN 4 UTAH PEDIGREES [J].
WILLIAMS, RR ;
HASSTEDT, SJ ;
WILSON, DE ;
ASH, KO ;
YANOWITZ, FF ;
REIBER, GE ;
KUIDA, H .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 255 (02) :219-224